The new data requirements for European agrochemical Regulations 283/2013 and 284/2013 reflect a shift toward a more pharma-like development process. How will these impact your risk assessment program?

View our webinar to learn how the new rules for in vitro data and its interpretation will affect the development and registration of your plant protection products.


  • Mira Wenker, PhD, ERT, Section Head, Drug Metabolism and Pharmacokinetics, Charles River
  • Sabitha Papineni, DVM, PhD, Senior Toxicologist, Regulatory Sciences and Government Affairs, Dow AgroSciences